Clinical trials company BDD has secured a further round of investment for £2 million to aid expansion of its patented drug delivery technology and.
/PRNewswire/ Instylla, Inc., a privately held company developing next-generation liquid embolics for peripheral vascular embolotherapy, today announced the.